A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2011
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN102210636A Antibacterial and skin-moisturizing shaving cream
10/12/2011	CN102210635A Polyamide 10.10 powder and its use in personal care products
10/12/2011	CN101879281B Formula of honey refined gum for treating chloasma and preparation method thereof
10/12/2011	CN101850093B Medicinal composition for treating hyperplasia of mammary glands
10/12/2011	CN101829263B Traditional Chinese medicinal composition for treating redness and preparation thereof
10/12/2011	CN101559120B Traditional Chinese medicinal ointment for treating radioepidermitis
10/12/2011	CN101433713B GnRH-PE mutant fusion protein and uses thereof
10/12/2011	CN101428112B Formulation for treating acne and preparation method thereof
10/12/2011	CN101411750B Oral Chinese medicine for treating chronic urticaria
10/12/2011	CN101375933B Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
10/12/2011	CN101332261B External medicine for treating furunculosis
10/12/2011	CN101317914B Decoction medicament for treating scabies
10/12/2011	CN101313959B Plaster medicament for treating scabies
10/12/2011	CN101301342B Soaking medicament for treating hyperkeratotic tinea manuum and tinea pedis
10/12/2011	CN101301336B Decoction medicament for treating localized neurodermatitis
10/12/2011	CN101199822B Capsule medicament for treating qi blood estrangement vitiligo
10/12/2011	CN101199633B Paste medicament for treating folliculitis
10/12/2011	CN101195009B Powder medicament for treating scrotum eczema
10/12/2011	CN101194976B Cleaning medicament for treating scald head
10/12/2011	CN101181381B Chinese medicine composition for curing alopecia areata, calvities, exiguous human hair
10/12/2011	CN101002765B Compressed formed preparation
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
10/11/2011	DE202010004750U1 Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut Pharmaceutical and / or cosmetic composition for treating the skin
10/11/2011	CA2727735C Disinfectant and/or bactericidal aqueous compositions
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2483620C Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitis, asthma or urticaria
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011123665A1 Methods and compositions for the treatment of burns and wounds
10/06/2011	WO2011123619A2 Permeable mixtures, methods and compositions for the skin
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122611A1 Cancer vaccine
10/06/2011	WO2011121366A1 Pyrazole p38 map kinase inhibitors
10/06/2011	WO2011121051A2 Preparation created from an in vitro culture of dedifferentiated, non-elicited cells of the argania tree, use thereof for treating skin ageing, inflammation and scarring, and production thereof
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	WO2010107482A3 Germicidal composition
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245759 Methods of Treating An Infection with Nitric Oxide
10/06/2011	US20110245351 Medical adhesive for surgery
10/06/2011	US20110245303 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245238 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245192 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
10/06/2011	US20110245184 Treatment of surgical adhesions
10/06/2011	US20110245181 Compositions and Methods for Skin Treatment
10/06/2011	US20110245149 Methods to prevent and treat diseases
10/06/2011	US20110244564 Cystine knot molecules
10/06/2011	US20110244063 Novel sebum secretion inhibitory agent
10/06/2011	US20110244054 Scaffold material for wound care and/or other tissue healing applications
10/06/2011	US20110244043 Controlled releasing composition
10/06/2011	US20110244006 Microsphere skin treatment
10/06/2011	US20110243985 Self-adhesive matrix system comprising a styrene block copolymer
10/06/2011	US20110243970 Composition for inhibition of transplant rejection containing the cordyceps mycellia extract as an active ingredient
10/06/2011	US20110243963 Antibodies to lrp6
10/06/2011	US20110243962 Therapeutic use of specific ligand in msrv associated diseases
10/06/2011	US20110243946 Remedies for pemphigus containing anti Fas ligand antibodies
10/06/2011	US20110243945 Anti-Inflammatory Agents
10/06/2011	US20110243943 Treatment using relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243942 Relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243932 Anti-cd40 antibodies
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243920 Compositions and methods for treating collagen-mediated diseases
10/06/2011	US20110243919 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243907 Cosmetic and nutritional alpha-omega complex composition
10/06/2011	US20110243903 Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243856 Permeable Mixtures, Methods and Compositions for the Skin
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2795248A1 Cell therapy to improve wound healing and related compositions and methods
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/06/2011	CA2794594A1 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
10/06/2011	CA2794115A1 Preparation created from an in vitro culture of dedifferentiated, non-elicited cells of the argania tree, use thereof for treating skin ageing, inflammation and scarring, and production thereof
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371840A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2371375A1 Peptide for inhibiting skin aging
10/05/2011	EP2371368A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions
10/05/2011	EP2371361A1 Methods to mobilize progenitor/stem cells
10/05/2011	EP2371351A1 Pharmaceutical composition for the treatment of solar urticaria
10/05/2011	EP2371350A1 Foam formulas for treating animal skin illnesses
10/05/2011	EP2370089A1 Compounds and methods for the treatment of autoimmune and inflammatory disease
10/05/2011	EP2370079A2 Hsp90 inhibitors for therapeutic treatment

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1065